Company: HCTI
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045994
Chunk: 95

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 8
Chunk 95
---
 thereto all included elsewhere in this prospectus.
The statements in this discussion regarding industry outlook, our expectations regarding our future performance, liquidity, and capital
resources, and all other non-historical statements in this discussion are forward-looking statements and are based on the beliefs of our
management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially
from those discussed in or implied by forward looking statements as a result of various factors, including those discussed below and elsewhere
in this report, and in the sections entitled “Special Note Regarding Forward-Looking Statements” and “Risk Factors”
contained in the Company’s final prospectus for its initial public offering filed with the Securities and Exchange Commission (“SEC”).

Overview 

Healthcare Triangle, Inc. (the “Company”)
is a leading healthcare information technology company focused on advancing innovative, industry-transforming solutions in the areas of
cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry.

The Company was formed on October 29, 2019, as
a Nevada corporation and then converted into a Delaware corporation on April 24, 2020, to provide IT and data services to the Healthcare
and Life Sciences (“HCLS”) industry. The business commenced on January 1, 2020, after SecureKloud Technologies Inc, transferred
its Life Sciences business to us. As of March 31, 2024, we had a total of 44 full time employees, 41 sub-contractors, including 24 certified
cloud engineers, 6 Epic Certified EHR experts and 11 MEDITECH Certified EHR experts. Many of the senior management team and the members
of our board of directors hold advanced degrees and some are leading experts in the field of technology, investment banking and public
markets.

During the quarter ended March 31, 2025, the Company
generated revenues of approximately $3.7 million compared to revenue of $4.1 million for the quarter ended March 31, 2024 which represents
a decrease of $0.4 million or 10% compared to the previous year.

Our approach leverages our proprietary technology
platforms, extensive industry knowledge, and healthcare domain expertise to provide solutions and services that reinforce healthcare progress.
Through our platform, solutions, and services, we support healthcare delivery organizations, healthcare insurance companies, pharmaceutical,
and Life Sciences, biotech companies, and medical device manufacturers in their efforts to improve data management, develop